Testing effectiveness (Phase 2)UnknownNCT01701479What this trial is testingLong Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)Who this might be right forNeuroblastoma St. Anna Kinderkrebsforschung 288
Early research (Phase 1)Study completedNCT00003750What this trial is testingBiological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other TumorsWho this might be right forMelanoma (Skin)NeuroblastomaSarcoma+1 more Children's Oncology Group 28
Early research (Phase 1)Looking for participantsNCT07106827What this trial is testingGV20-0251 in Advanced or Refractory Solid TumorsWho this might be right forHCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more West China Hospital 10
Early research (Phase 1)Study completedNCT00005813What this trial is testingBispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT01517776What this trial is testingCilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and AdolescentsWho this might be right forGliomas Martin-Luther-Universität Halle-Wittenberg 28
Early research (Phase 1)WithdrawnNCT04125719What this trial is testingPVSRIPO in Combination With Nivolumab in MelanomaWho this might be right forMelanoma Darell Bigner
Early research (Phase 1)Looking for participantsNCT04185038What this trial is testingStudy of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System TumorsWho this might be right forCentral Nervous System TumorDiffuse Intrinsic Pontine GliomaDiffuse Midline Glioma+8 more Seattle Children's Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT02332668What this trial is testingPembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)Who this might be right forMelanomaLymphomaSolid Tumor+2 more Merck Sharp & Dohme LLC 370
Early research (Phase 1)Study completedNCT02115074What this trial is testingSafety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic GliomasWho this might be right forGlioma Centre Oscar Lambret 20
Early research (Phase 1)Study completedNCT03501368What this trial is testingStudy of Trametinib + Ceritinib in Patients With Unresectable MelanomaWho this might be right forMelanomaUnresectable MelanomaAdvanced Melanoma H. Lee Moffitt Cancer Center and Research Institute 27
Early research (Phase 1)Study completedNCT01713439What this trial is testingAllogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALLWho this might be right forNeuroblastoma Baylor College of Medicine 32
Very early researchLooking for participantsNCT06684639What this trial is testingA Study on the Efficacy of GD2-CAR T Cells in the Treatment of NeuroblastomaWho this might be right forNeuroblastoma The General Hospital of Western Theater Command 30
Testing effectiveness (Phase 2)Ended earlyNCT03860207What this trial is testingStudy of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor CancersWho this might be right forNeuroblastomaOsteosarcomaOther Solid Tumor Cancers Y-mAbs Therapeutics 12
Not applicableAvailableNCT06404034What this trial is testingExpanded Access to Gallium Maltolate (GaM)Who this might be right forGlioblastomaRefractory GlioblastomaGlioblastoma Multiforme Imaging Biometrics, LLC
Early research (Phase 1)Ended earlyNCT01088763What this trial is testingGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaWho this might be right forChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more National Cancer Institute (NCI) 129
Testing effectiveness (Phase 2)Study completedNCT03950830What this trial is testingDisulfiram and Cisplatin in Refractory TGCTs.Who this might be right forGerm Cell Tumor National Cancer Institute, Slovakia 12
Early research (Phase 1)Study completedNCT00625456What this trial is testingSafety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsWho this might be right forMelanomaLung CancerRenal Cell Carcinoma+1 more Jennerex Biotherapeutics 23
Early research (Phase 1)Looking for participantsNCT04308330What this trial is testingVorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS MalignanciesWho this might be right forEwing SarcomaRhabdomyosarcomaWilms Tumor+3 more New York Medical College 30
Testing effectiveness (Phase 2)Ended earlyNCT00003472What this trial is testingAntineoplaston Therapy in Treating Patients With Recurrent or Refractory OligodendrogliomaWho this might be right forOligodendroglioma, Adult Burzynski Research Institute 13
Testing effectiveness (Phase 2)Study completedNCT04993677What this trial is testingSEA-CD40 Given With Other Drugs in CancersWho this might be right forMelanomaCarcinoma, Non-Small- Cell Lung Seagen Inc. 77